Annual ROE
-41.98%
+16.22%+27.87%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual return on equity is -41.98%, with the most recent change of +16.22% (+27.87%) on March 31, 2024.
- During the last 3 years, IMVT annual ROE has fallen by -14.54% (-52.99%).
- IMVT annual ROE is now -52.99% below its all-time high of -27.44%, reached on March 31, 2021.
Performance
IMVT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-77.94%
-21.54%-38.19%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly return on equity is -77.94%, with the most recent change of -21.54% (-38.19%) on December 31, 2024.
- Over the past year, IMVT quarterly ROE has dropped by -16.83% (-27.54%).
- IMVT quarterly ROE is now -19109.76% below its all-time high of 0.41%, reached on September 30, 2019.
Performance
IMVT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
IMVT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.9% | -27.5% |
| 3 y3 years | -53.0% | -154.5% |
| 5 y5 years | +40.5% | -500.5% |
IMVT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.0% | +27.9% | -154.5% | at low |
| 5 y | 5-year | -53.0% | +40.5% | -500.5% | at low |
| alltime | all time | -53.0% | +40.5% | <-9999.0% | at low |
Immunovant ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -77.94%(+38.2%) |
| Sep 2024 | - | -56.40%(+8.3%) |
| Jun 2024 | - | -52.07%(-7.2%) |
| Mar 2024 | -41.98%(-27.9%) | -56.11%(-8.2%) |
| Dec 2023 | - | -61.11%(-20.5%) |
| Sep 2023 | - | -76.84%(+15.7%) |
| Jun 2023 | - | -66.41%(+26.7%) |
| Mar 2023 | -58.20%(+74.5%) | -52.43%(+13.2%) |
| Dec 2022 | - | -46.30%(+18.3%) |
| Sep 2022 | - | -39.14%(+14.4%) |
| Jun 2022 | - | -34.22%(+2.5%) |
| Mar 2022 | -33.36% | -33.40%(+9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | -30.63%(+2.1%) |
| Sep 2021 | - | -30.01%(+8.6%) |
| Jun 2021 | - | -27.63%(-2.8%) |
| Mar 2021 | -27.44%(-61.1%) | -28.42%(-13.6%) |
| Dec 2020 | - | -32.88%(-5.5%) |
| Sep 2020 | - | -34.80%(-12.6%) |
| Jun 2020 | - | -39.81%(+36.5%) |
| Mar 2020 | -70.57% | -29.16%(+124.7%) |
| Dec 2019 | - | -12.98%(-3265.9%) |
| Sep 2019 | - | 0.41%(+28.1%) |
| Jun 2019 | - | 0.32%(-119.3%) |
| Mar 2019 | - | -1.66% |
FAQ
- What is Immunovant annual return on equity?
- What is the all time high annual ROE for Immunovant?
- What is Immunovant annual ROE year-on-year change?
- What is Immunovant quarterly return on equity?
- What is the all time high quarterly ROE for Immunovant?
- What is Immunovant quarterly ROE year-on-year change?
What is Immunovant annual return on equity?
The current annual ROE of IMVT is -41.98%
What is the all time high annual ROE for Immunovant?
Immunovant all-time high annual return on equity is -27.44%
What is Immunovant annual ROE year-on-year change?
Over the past year, IMVT annual return on equity has changed by +16.22% (+27.87%)
What is Immunovant quarterly return on equity?
The current quarterly ROE of IMVT is -77.94%
What is the all time high quarterly ROE for Immunovant?
Immunovant all-time high quarterly return on equity is 0.41%
What is Immunovant quarterly ROE year-on-year change?
Over the past year, IMVT quarterly return on equity has changed by -16.83% (-27.54%)